Jennifer A Jenks

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Venues

PLoS pathogens

The Journal of infectious diseases

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xintao Hu, Krithika P Karthigeyan, Savannah Herbek, Sarah M Valencia, Jennifer A Jenks, Helen Webster, Itzayana G Miller, Megan Connors, Justin Pollara, Caroline Andy, Linda M Gerber, Emmanuel B Walter, Kathryn M Edwards, David I Bernstein, Jacob Hou, Matthew Koch, Lori Panther, Andrea Carfi, Kai Wu, Sallie R Permar
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine. The Journal of infectious diseases 230 (2) (2024)
Xintao Hu, Krithika P Karthigeyan, Savannah Herbek, Sarah M Valencia, Jennifer A Jenks, Helen Webster, Itzayana G Miller, Megan Connors, Justin Pollara, Caroline Andy, Linda M Gerber, Emmanuel B Walter, Kathryn M Edwards, David I Bernstein, Jacob Hou, Matthew Koch, Lori Panther, Andrea Carfi, Kai Wu, Sallie R Permar
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine. The Journal of infectious diseases 230 (2) (2024)
Xintao Hu, Krithika P Karthigeyan, Savannah Herbek, Sarah M Valencia, Jennifer A Jenks, Helen Webster, Itzayana G Miller, Megan Connors, Justin Pollara, Caroline Andy, Linda M Gerber, Emmanuel B Walter, Kathryn M Edwards, David I Bernstein, Jacob Hou, Matthew Koch, Lori Panther, Andrea Carfi, Kai Wu, Sallie R Permar
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine. The Journal of infectious diseases 230 (2) (2024)
Xintao Hu, Krithika P Karthigeyan, Savannah Herbek, Sarah M Valencia, Jennifer A Jenks, Helen Webster, Itzayana G Miller, Megan Connors, Justin Pollara, Caroline Andy, Linda M Gerber, Emmanuel B Walter, Kathryn M Edwards, David I Bernstein, Jacob Hou, Matthew Koch, Lori Panther, Andrea Carfi, Kai Wu, Sallie R Permar
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine. The Journal of infectious diseases (2024)
Jennifer A Jenks, Sharmi Amin, Madeline R Sponholtz, Amit Kumar, Daniel Wrapp, Sravani Venkatayogi, Joshua J Tu, Krithika Karthigeyan, Sarah M Valencia, Megan Connors, Melissa J Harnois, Bhavna Hora, Eric Rochat, Jason S McLellan, Kevin Wiehe, Sallie R Permar
A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus. PLoS pathogens 19 (1) (2023)
Jennifer A Jenks, Sharmi Amin, Madeline R Sponholtz, Amit Kumar, Daniel Wrapp, Sravani Venkatayogi, Joshua J Tu, Krithika Karthigeyan, Sarah M Valencia, Megan Connors, Melissa J Harnois, Bhavna Hora, Eric Rochat, Jason S McLellan, Kevin Wiehe, Sallie R Permar
A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus. PLoS pathogens 19 (1) (2023)
Jennifer A Jenks, Sharmi Amin, Madeline R Sponholtz, Amit Kumar, Daniel Wrapp, Sravani Venkatayogi, Joshua J Tu, Krithika Karthigeyan, Sarah M Valencia, Megan Connors, Melissa J Harnois, Bhavna Hora, Eric Rochat, Jason S McLellan, Kevin Wiehe, Sallie R Permar
A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus. PLoS pathogens 19 (1) (2023)
Jennifer A Jenks, Sharmi Amin, Madeline R Sponholtz, Amit Kumar, Daniel Wrapp, Sravani Venkatayogi, Joshua J Tu, Krithika Karthigeyan, Sarah M Valencia, Megan Connors, Melissa J Harnois, Bhavna Hora, Eric Rochat, Jason S McLellan, Kevin Wiehe, Sallie R Permar
A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus. PLoS pathogens 19 (1) (2023)
Jennifer A Jenks, Sharmi Amin, Madeline R Sponholtz, Amit Kumar, Daniel Wrapp, Sravani Venkatayogi, Joshua J Tu, Krithika Karthigeyan, Sarah M Valencia, Megan Connors, Melissa J Harnois, Bhavna Hora, Eric Rochat, Jason S McLellan, Kevin Wiehe, Sallie R Permar
A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus. PLoS pathogens 19 (1) (2023)
Jennifer A Jenks, Sharmi Amin, Madeline R Sponholtz, Amit Kumar, Daniel Wrapp, Sravani Venkatayogi, Joshua J Tu, Krithika Karthigeyan, Sarah M Valencia, Megan Connors, Melissa J Harnois, Bhavna Hora, Eric Rochat, Jason S McLellan, Kevin Wiehe, Sallie R Permar
A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus. PLoS pathogens 19 (1) (2023)
Jennifer A Jenks, Cody S Nelson, Hunter K Roark, Matthew L Goodwin, Robert F Pass, David I Bernstein, Emmanuel B Walter, Kathryn M Edwards, Dai Wang, Tong Ming Fu, Zhiqiang An, Cliburn Chan, Sallie R Permar
Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans. Science translational medicine 12 (568) (2021)

Jennifer A Jenks.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jennifer A Jenks